These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3296928

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P.
    Cardiologia; 1998 Jun; 43(6):617-23. PubMed ID: 9675961
    [Abstract] [Full Text] [Related]

  • 44. Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
    Cai WM, Xu J, Chen B, Zhang FM, Huang YZ, Zhang YD.
    Acta Pharmacol Sin; 2002 Nov; 23(11):1040-4. PubMed ID: 12421483
    [Abstract] [Full Text] [Related]

  • 45. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ, Facchini M, Bonazzi O, Cuspidi C, Priori S, Varisco T, Zuanetti G.
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [Abstract] [Full Text] [Related]

  • 46. [The efficacy of intravenous propafenone and amiodarone in the conversion of recent-onset atrial fibrillation. A 1-year follow-up with oral treatment].
    Bellandi F, Cantini F, Pedone T, Dabizzi RP, Palchetti R.
    G Ital Cardiol; 1993 Mar; 23(3):261-71. PubMed ID: 8325461
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Efficacy and tolerance of propafenone after correction of atrial fibrillation: PEPS pharmaco-epidemiologic study].
    Simon T, Mary-Krause M, Funck-Brentano C, Davy JM, Weingrod M, Jaillon P.
    Arch Mal Coeur Vaiss; 2002 Jun; 95(6):567-72. PubMed ID: 12138815
    [Abstract] [Full Text] [Related]

  • 50. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 51. [Evaluation of the clinical acute electrophysiological effects of propafenone using transesophageal atrial pacing].
    He F, Zhao X, Cheng X.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun 18; 16(3):239-41. PubMed ID: 7528645
    [Abstract] [Full Text] [Related]

  • 52. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN, Kaplinsky E, Kirsten E, Guerrero J.
    Am Heart J; 1988 Dec 18; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [Abstract] [Full Text] [Related]

  • 53. [Significance of the degree of oxidative hepatic metabolism in conditioning the pharmacokinetics and the pharmacodynamics of propafenone].
    Boriani G, Capucci A, Strocchi E, Marchesini B, Baroni M, Frabetti L, Ambrosioni E, Magnani B.
    G Ital Cardiol; 1991 May 18; 21(5):517-26. PubMed ID: 1936756
    [Abstract] [Full Text] [Related]

  • 54. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF, Coumel P.
    Arch Mal Coeur Vaiss; 1983 Oct 18; 76(10):1218-30. PubMed ID: 6418100
    [Abstract] [Full Text] [Related]

  • 55. [Intermediate-term trial treatment of arrhythmia in hypertrophic myocardiopathy with sotalol].
    Fournier C, Bourmayan C, Cadillac M, Dinanian J, Blondeau M, Gay J.
    Ann Cardiol Angeiol (Paris); 1988 Apr 18; 37(4):211-3. PubMed ID: 2967045
    [Abstract] [Full Text] [Related]

  • 56. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M, Hohnloser S, Geibel A, Furtwängler A, Olschewski M, Meinertz T, Just H.
    Br Heart J; 1992 Jun 18; 67(6):491-7. PubMed ID: 1622701
    [Abstract] [Full Text] [Related]

  • 57. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G, Capucci A, Balducelli M, Frabetti L, Marchesini B, Tomasi L, Ambrosioni E, Magnani B.
    Cardiologia; 1988 Nov 18; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract] [Full Text] [Related]

  • 58. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H, Baker BJ, de Soyza N, Murphy ML.
    Am Heart J; 1988 Jan 18; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [Abstract] [Full Text] [Related]

  • 59. [Sulfasalazine or salazosulfapyridine in the treatment of rheumatoid polyarthritis. An open study of 46 patients. Review of the literature].
    Trèves R, Morvan C, Bitaudeau P, Clément S, Liozon E, Arnaud M, Archambeaud-Mouveroux F, Desproges-Gotteron R.
    Rev Rhum Mal Osteoartic; 1988 Jan 18; 55(9):641-6. PubMed ID: 2903546
    [Abstract] [Full Text] [Related]

  • 60. [Clinical evaluation of fludilat in cerebrovascular insufficiency].
    García Guerra CM.
    Prensa Med Mex; 1977 Jan 18; 42(11-12):504-8. PubMed ID: 351600
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.